Percutaneous Coronary Intervention Guidance Devices Market

Report Description

Percutaneous Coronary Intervention Guidance Devices Market Outlook 2032

The global percutaneous coronary intervention guidance devices market size was USD 13.8 Billion in 2023 and is projected to reach USD 24.4Billion by 2032, expanding at a CAGR of 6.5% during 2024–2032. The market growth is attributed to the increasing prevalence of cardiovascular diseases and ­­rising preference for minimally invasive procedures.

Cardiovascular diseases (CVDs) are the leading cause of deaths globally. Heart and blood vessel disorders that are typically referred as CVDs include rheumatic heart disease, coronary heart disease, and cerebrovascular disease. Heart attacks and strokes account for more than four out of every five deaths from CVD, and one-third of these deaths happens unexpectedly early under the age of 70.

Percutaneous coronary intervention (PCI) is an invasive and non-surgical procedure, which dilates the narrowing or occlusion of the coronary artery and improves the blood circulation throughout the body. Different methods are used to perform this process, such as balloon stents, which are used to open the artery. Equipment used for percutaneous coronary intervention are introducer needle, sheath introducer, guide catheters, IV contrast, guidewire, balloon catheter, and stents.

• In 2019, according to World Health Organization (WHO), an estimated 17.9 million people died from CVDs, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.

Accuracy of these PCI equipment is highly precise and minimally invasive, hence, offers a fast recovery time and less blood loss. A standardized approach to incorporating intravascular imaging with percutaneous coronary intervention is expected to get over the barriers and used largely with high precision & accuracy.

Get Free Sample Report

Impact of Artificial Intelligence (AI) in the Percutaneous Coronary Intervention Guidance Devices Market

Artificial Intelligence has an accelerating impact on percutaneous coronary intervention guidance devices market. The image analysis and diagnostic accuracy are expected to get enhanced with the help of AI and machine learning. The enhanced diagnostics and decision makings by the automatic analysis of angiographic images, generated with AI, is predicted to assist the physician with increasingly accurate treatment and procedures.

Improved patient safety with the automated selections of optimal stent provides personalized approach, which is expected to enhance the accuracy and improved outcomes. Moreover, the real time guidance and support with the help of HD images of angiography provides an assistance to the physicians in navigating the catheter, positioning the stents, and optimizing procedure outcomes.

AI is being used in various medical procedures, including automated stent selection, robotic-assisted interventions, and predictive maintenance. It analyzes patient data and angiographic images to recommend the well-suited stent size and type, improving efficiency and reducing long-term complications. AI-powered robotic systems also assist physicians in precise catheter navigation, reducing operator fatigue and enhancing safety.

Percutaneous Coronary Intervention Guidance Devices Market Dynamics

Get Free Sample Report

Major Drivers

Increasing number of patients diagnosed for CVDs is driving the global percutaneous coronary intervention guidance devices market. According to the American Heart Association, CVD is the major health issue globally, and also increasing the death rates exponentially.

Rising preference of minimally invasive procedure is increasing the demand for these procedures, boosting the market. Moreover, growing geriatric population is increasing the number of critical CVDs cases and accelerating the need of percutaneous coronary intervention procedures.

The surge in an unhealthy lifestyle due to high consumption of alcohol, tobacco, food containing unsaturated fatty acids, and a sedentary lifestyle without any physical activities results in chronic health conditions and affects the heart. This is leading to heart disease and propelling the global market.

Advancements in treatment procedures is helping the physicians to accurately navigate and reach the blood vessels with novel and personalized product types. Increasing R&D activities is expected to fuel the market during the forecast period.

Existing Restraints

High cost associated with minimally invasive procedures, due to their precision, advanced treatment approach, and top-notch infrastructure, is anticipated to restrain the market during the forecast period. Lack of skilled professionals are expected to hinder the market in the coming years. Moreover, the changing regulatory landscape in medical procedures and devices are projected to hinder the market during the forecast period.   

Emerging Opportunities

Significant advancements and changes are creating opportunities for improved patient outcomes. Integration of Artificial Intelligence (AI), advanced imaging technologies, next-generation catheters and guidewires, and robotic surgeries offer growth opportunities for the market players. AI enhances the decision-making by analyzing vast amounts of data, predicting complications, and providing real-time guidance during procedures. Technological advancements such as fractional flow reserve (FFR) and intravascular optical coherence tomography (OCT) offer precise assessments of blood flow and plaque characteristics, enabling enhanced decision-making during PCI.

Remote monitoring and telehealth improve access to care, particularly in underserved areas. Remote monitoring devices collect vital signs and other data, enabling early detection of potential complications and facilitating timely interventions. This potentially reduces healthcare costs by minimizing unnecessary hospital visits and readmissions.

Growing preference for minimally invasive approaches for PCI procedures creates the demand for specialized catheters and guidewires tailored for this entry point. Minimizing the size and profile of devices is expected to further reduce patient discomfort and improve procedural outcomes. Advancements in materials and techniques are predicted to enhance patient comfort during and after PCI procedures, leading to fast recovery and improved satisfaction.

Development of cost-effective solutions, training healthcare professionals in emerging economies, and collaborating between government agencies, medical device companies, & healthcare institutions facilitate the development and distribution of accessible PCI guidance technologies. These emerging opportunities hold significant potential to improve the effectiveness and accessibility of PCI procedures, ultimately leading to improved patient outcomes and reduced healthcare burdens globally.

Scope of the Percutaneous Coronary Intervention Guidance Devices Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Percutaneous Coronary Intervention Guidance Devices Market Segment Insights

Product Type Segment Analysis

Based on product type, the percutaneous coronary intervention guidance devices market is divided into percutaneous sheath catheter, guide catheter, guide wire, and imaging devices. The guide catheter segment held the major share of the market in 2023, owing to it being the safest option among all other intervention product. Moreover, the high efficiency and accuracy of guide catheter boost the segment. Balloon catheter is the common type of guide catheter, which is a soft catheter with an inflatable balloon that is inserted into narrow opening or passage within the body. Advancements in guide catheters is driving the segment.

Get Free Sample Report

Application Segment Analysis

On the basis of application, the global percutaneous coronary intervention guidance devices market is segregated into stable coronary syndrome, acute coronary syndrome, complex coronary intervention, peripheral coronary intervention, and structural heart intervention. The stable coronary artery disease segment held a large market share in 2023. The high prevalence and repeated revascularization procedures throughout the lifetime of patients is leading to the high demand for the guidance devices. Additionally, the suitability of the diagnostic procedure and lower complexity as compared to other disease such as structural heart intervention and peripheral coronary intervention, which require highly complex procedures and required manipulation, is boosting this segment. 

The complex coronary intervention segment is anticipated to expand at a substantial CAGR during the forecast period. This expansion in the market is attributed to the rising number of the complex PCI procedures. Furthermore, the awareness among the population for this segment and adaption of technical advancements are expected to drive the market during the forecast period.  

Vascular Access Segment Analysis

Based on vascular access, the percutaneous coronary intervention guidance devices market is segmented into radial and femoral. The radial segment attributed a significant market revenue in 2023, owing to the minimally invasive procedure. The radial access requires a small puncture into the skin and therefore, leading to a fast recovery, less bleeding, and improved patient outcomes. Lesser complications associated with this procedure is leading to growing adoption of radial procedures among the patients, driving the segment. Moreover, the technical advancements in designing personalized guide wires are expect to boost the segment in the coming years.  

Get Free Sample Report

End-user Segment Analysis

On the basis of end-user, the percutaneous coronary intervention guidance devices market is divided into hospitals, ambulatory surgical centers, and cardiac catheter laboratory. The hospitals segment generated a major revenue share of the market in 2023, due to hospital being the preferable option for the coronary intervention patients for a better recovery and scheduled patient monitoring. The advanced hospital infrastructure and availability of latest resources with highly skilled staffs to access them are driving the segment. Additionally, the high volume of procedures and growing geriatric population needing long hospital stays after the procedure is propelling the segment.

Regional Outlook

In terms of region, the global percutaneous coronary intervention guidance devices market is classified as Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. North America held a major market share in 2023, due to top notch infrastructure and adoption of advanced infrastructure. Additionally, the presence of key market players, increasing R&D activities, and rising collaborations among the population is driving the market. Moreover, the favorable reimbursement policies for minimally invasive procedures are also driving the demand for percutaneous coronary intervention guidance devices in North America, boosting the market.

The market in Europe is projected to expand at a significant pace in the coming years, owing to the rising number of patients suffering from cardiovascular disease. Furthermore, the advancements in technologies and rising healthcare expenditure are driving the market in the region.

Get Free Sample Report